Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences

Fast-acting insulin aspart (faster aspart) is insulin aspart (IAsp) with two added excipients, L-arginine and niacinamide, to ensure formulation stability with accelerated initial absorption after subcutaneous administration compared with previously developed rapid-acting insulins. The pharmacokinet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanne Haahr, Tim Heise
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2020
Materias:
Acceso en línea:https://doaj.org/article/8f6ea16d2b274e568069cac42f9f1865
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!